COCHW · Envoy Medical, Inc. · Documents
$0.03
-0.01 (-21.91%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Since inception, the Company has historically incurred negative operating cash flows and losses from operations as the Company advances the clinical development of its products and the funding process of clinical FDA trials. These matters raise substantial doubt about the Company's ability to continue as a going concern and although management has developed plans intended to support ongoing operations, such plans do not alleviate the substantial doubt.”View the 10-Q filed Aug 10, 2026
Market Cap
$46.00M
Shares
77.19M
Volume · Oct 21
10K
Avg daily vol (3M)
32.54K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-10-20 | 2023-10-16 | |
| 8-K | — | 2023-10-10 | — | |
| 8-K/A | — | 2023-10-10 | 2023-09-29 | |
| 8-K | — | 2023-10-05 | 2023-09-29 | |
| 8-K | — | 2023-10-02 | 2023-09-29 | |
| 8-K | — | 2023-09-27 | — | |
| DEFA14A | — | 2023-09-15 | — | |
| DEF 14A | — | 2023-09-15 | 2023-09-29 | |
| 8-K | — | 2023-09-15 | — | |
| S-4/A | — | 2023-09-13 | — | |
| S-4/A | — | 2023-09-05 | — | |
| PRE 14A | — | 2023-09-05 | 2023-09-29 | |
| S-4/A | — | 2023-08-24 | — | |
| 10-Q | — | 2023-08-14 | 2023-06-30 | |
| S-4/A | — | 2023-08-04 | — | |
| S-4/A | — | 2023-06-30 | — | |
| 10-Q | — | 2023-05-15 | 2023-03-31 | |
| S-4 | — | 2023-05-15 | — | |
| 8-K | — | 2023-04-18 | 2023-04-17 | |
| NT 10-K | — | 2023-04-03 | 2022-12-31 | |
| 10-K | — | 2023-04-03 | 2022-12-31 | |
| 8-K | — | 2023-04-03 | 2023-03-28 | |
| 8-K | — | 2023-03-02 | 2023-02-28 | |
| DEFA14A | — | 2023-02-24 | — | |
| 8-K | — | 2023-02-24 | 2023-02-23 | |
| DEFA14A | — | 2023-02-22 | — | |
| 8-K | — | 2023-02-22 | — | |
| 8-K | — | 2023-02-21 | — | |
| DEFA14A | — | 2023-02-21 | — | |
| DEFA14A | — | 2023-02-21 | — | |
| 8-K | — | 2023-02-09 | — | |
| DEFA14A | — | 2023-02-09 | — | |
| DEFA14A | — | 2023-02-06 | — | |
| 8-K | — | 2023-02-06 | — | |
| DEFA14A | — | 2023-02-03 | — | |
| DEF 14A | — | 2023-01-20 | 2023-02-09 | |
| PRE 14A | — | 2022-12-29 | 2022-12-28 | |
| 10-Q | — | 2022-11-14 | 2022-09-30 | |
| 8-K | — | 2022-10-04 | 2022-10-01 | |
| 10-Q | — | 2022-08-15 | 2022-06-30 | |
| 8-K | — | 2022-08-04 | 2022-07-29 | |
| 10-Q | — | 2022-05-16 | 2022-03-31 | |
| 10-K | — | 2022-03-31 | 2021-12-31 | |
| 8-K/A | — | 2022-01-26 | 2021-03-04 | |
| 10-Q/A | — | 2022-01-03 | 2021-09-30 | |
| 8-K | — | 2021-12-07 | 2021-12-06 | |
| 8-K | — | 2021-12-03 | 2021-12-02 | |
| 10-Q | — | 2021-11-12 | 2021-09-30 | |
| 10-Q | — | 2021-08-18 | 2021-06-30 | |
| NT 10-Q | — | 2021-08-17 | 2021-06-30 |
Showing 101–150 of 157 filings